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MAP-kinases. As evidenced by ERK phosphorylation, concentrations as low as 0.1 ng/ml 
were sufficient for this mechanism. Pretreatment with pertussis toxin (PTX) inhibited 
MCP-l-dependent ERK phosphoryletion. MCP-1 also induced secretion of matrix metal- 
Iopreteinase (MMP)-2 which along with ERK activation was inhibited by PD98059. 
Conclusion: The results demonstrate that MCP-1 can lead to direct activation of MAP 
kinases together with induction of MMPs in EC. Our data thus propose a new mechanism 
for the proatherogenic effect of MCP-1, 
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880-5 Product ion  of  MCP-1 by Human Aortic Endothelial 
Cells, Upon Depletion of Nutrients, Requires Rac 1 
Neuza H. LoDes, Sanjay S. Vasudevan, Herve Kovacic, Pascal J. Goldschmidt-Clermont, 
Duke University Medical Center, Durham, North Carolina, Universite the La 
mediterrsnee, Marseille, France. 
Background: Following an episode of coronary occlusion, inflammatory cells accumu- 
late within small vessels of the coronary tree, and contribute to the injury that damages 
the myooardium. The chemokine monocyte chemoattractant protein-1 (MCP-1) is a key 
regulator of leukocyte recruitment o sites of inflammation. However, the exact molecular 
mechanism involved in controlling expression of MCP-1 in ischemic conditions remains 
unclear. The small GTP-binding protein Racl regulates the production of reactive oxygen 
species (ROS) by ubiquitous NADPH oxidase complex, the major source of superoxide 
in most cells. We investigated the effect of nutrient depletion, a condition associated with 
ischemia, on MCP-1 production in human aortic endothelial cells (HAEC) and the role of 
Rac-1 and reactive oxygen species in this process. Method==: Recombinant adenovi- 
ruses, for expression of either dominant negative (Racl-N17) or constitutively active 
(Racl-V12) mutants of Recl, geranylgeranyltransferase inhibitor GGTI-298 (10uM), or 
N-acetylcysteine (20mM) were used to study the role of Racl and ROS in MCP-1 
expression. Nutrient depletion (ND) was obtained by shifting HAEC from 10% to 0.5% 
FBS. MCP-1 production was measured by ELISA. Results: Nutrient depletion increased 
MCP-1 production by HAEC (4.8+/-0.66 fold, p<0.01), in a time dependent manner peak- 
ing at 24 hours. Expression of Rac1-V12 increased MCP-1 expression to a similar level, 
even in the absence of NP. Transduction of HAEC with Recl-N17 at 25 MOI decreased 
NP-induced MCP-t production (p=0.007). Likewise, NAC and GGTI-298, both decreased 
MCP-1 production (p<0.05 and p<0.001, respectively). Conclusion: These results sug- 
gest that nutrient depletion associated with ischemia is sufficient to induce MCP-1 pro- 
duction by HAEC, and that such production requires a functional Racl, redox-sensitive, 
pathway. 
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860-6 Motexafin Lutetium Phototherapy Induces Apoptoaie in 
Macrophages and Downregulates Monocyte 
Chemosttractant Protein Expression In Human 
Coronary Artery Smooth Muscle Cel ls  
Kathryn W. Woodburn, Yu Luo, Krishnankuttv Sudhir, Pharmacyclics, Sunnyvale, 
California. 
Background: Macrephage burden has been shown to be a main predictor for restenosis 
after percutaneous interventions. Monocyte chemoattractant protein (MCP-1) is a 
chemokine that is produced by stimulated endothelial cells and smooth muscle cells 
(SMCs), and is responsible for recruiting monooytes/macrophages into injured arterial 
walls. Motexafin lutetium (MLu), a photosensitizer, has been shown to reduce macroph- 
age burden in experimental models. The mechanism by which MLu phototherapy 
reduces macrophages and the impact that phototherapy has on MCP-1 production was 
evaluated. Methods: The subcellular localization of MLu was evaluated in human THP-1 
macrophages (ATCC) and coronary artery SMCs (Clonetios). Co-labeling studies were 
performed using organelle specific fluorogenic probes. After phototherapy; changes in 
nuclear morphology were assessed with Hoeshst 33342 staining; lysosomal integrity was 
evaluated using fluorescence after acridine orange staining; cytochrome C and cathepsin 
B distribution were ascertained using immunofiuorescence. Cellular viability experiments 
were performed with an M'l-I" (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrezolium bro-
mide) assay. RNA was harvested from SMCs for measurement of MCP-1 mRNA levels 
with the RibcQuant TM multi-probe RNase protection assay system (PharMingen), 
Results: MLu partitioned within macrophages and SMC lysosomes, Photosensitization 
led to lysosomal instability, release of intralysosomal cathepsin B into the cytoplasm, and 
the subsequent release of cytochrome C from the mitochondria. Chromatin condensation 
and nuclear blebbing, hallmark features of apoptosis, ensued. Photosensitization also 
caused downregulafion of MCP-1 in human coronary artery SMCs. Conclusions: Con- 
sidering the crucial and pivotal role that MCP-1 has in plaque progression, stabilization 
and in restenosis, it is likely that one of the mechanisms by which MLu-mediated photo- 
therapy exerts its effect on plaque resolution is through the apoptotic elimination of mac- 
rephages and via the downregulation of MCP-1 production. 
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863-1 New Classification of  Aort ic  D issect ion With Improved 
Impact on Prognosis 
Barbara M. Richartz. Dean E. Smith, Jeanna V. Cooper, Rajendra M. Mehta, Kim A. 
Eagle, Christoph A. Nienaber, on Behaff of International Registry of Acute Aortic 
Dissection (IRAD) Investigators, Ann Arbor, Michigan. 
Background: The entry site location is currently used to classify and stratify acute aortic 
dissection. Type A lesions require urgent surgical therapy to improve survival, while type 
B lesions often have a better outcome and benefit from stenting or medical management. 
In the attempt to use anatomic information for assessment of prognosis we correlated the 
entry site location of type A and B aortic dissection with 30-day-mortality. 
Methods: 820 patients with acute aortic dissection were enrolled in the database of the 
International Registry of Acute Aortic Dissection (IRAD). According to exact entry site 
location from diagnostic imaging we established 6 subgroups: aortic root (n = 197, 25%), 
ascending aorta (n = 291,36%), arch (n = 59, 9%), left subclavian area (n = 157, 19%), 
descending thoracic aorta (n = 85, 10%), and abdominal aorta (n = 21, < 1%) and deter- 
mined 30-day-mortality in each group, 
Results: Among type A aortic dissections significant differences in 30-day-mortality were 
found with a death rate of 37% in aortic root, 28% in ascending aorta, and 23% in the 
arch [p < 0.001]. Conversely, in type B aodic dissection modality did not differ between 
entry sites at left subclavian area (12%), descending thoracic aorta (13%), and abdomi- 
nal aorta (10%). Demographic data were similar in all groups. 
Conclusions: The closer the distance between entry site location and aortic root, the 
worse the prognosis of type A aodic dissection. Thus, prognosis in type A dissection is 
diverse and can be subclassified into 3 groups. Conversely, type B aortic dissection is 
homogeneous with respect to prognosis and subclassification is only descriptive. 
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863-2 Familial Aortic Dissection/Aneurysm Associated With 
Patent Ductus Arteriosus: A New Entity? 
Philieoa Khau Van Kien. Alain Lalande, Caroline Bonnet, Arnaud Delfinger, Annie Petit, 
Anne Nivelon-Chevallier, Fran~:ois Brunette, Xavier Jeunemaitre, Jean-Eric Wolf, CHU 
Becage, Dijon, France. 
Background: In March 2001, a first report from United States described an unusual family 
in which 5 members present a combination of thoracic aortic dissestion/aneurysm (TAD/ 
TAA) and patent ductus artedosus (PDA). The authors suggested a possible common 
genetic defects. We report a large French family with the same association. 
Subjects and methods: this family composed of 179 members was ascertained from a 
single probant. Forty first-degree relative subjects from three different generations have 
been enrolled in a ctinical investigation protocol composed of two pads: 
- a medical questionnaire concerning available medical records, state of health and 
allowing to investigate the familial history. A standardized clinical examination focused on 
classical signs of Marfan and Ehlers-Danlos syndromes. 
- An annual Iong-tarm follow-up based on: standardized cardiovascular examination, 
transthoracic echocardiography and a thoracic MRI, completed by transesophageal ultra- 
sonography when necessary, allowing the accurate measurement of the aorta, great ves- 
sels and heart. At the time of the inclusion, blood measurements of total and LDL-HDL 
cholesterol, triglycerides and glucose were performed 
Results: 9 cases of TAD and TAA among this family 4 TAD (2 males and 2 females) and 
5 TAA (4 males and 1 female). All the cases of TAA have been discovered in asymptom- 
atic subjects by screening. 8 cases of PDA without any particular neonatal context. 5 
cases of cerebral stroke with two of them due to a documented intracranian carotidian 
aneurysm, 3 cases of suspicious sudden death. All theses vascular findings cosegrege 
with cases of TAA/TAD in an autosomal dominant with incomplete penetrance pattern of 
inheritance. For all the probants there are no arguments for Marfan syndrome or Ehlers- 
Danlos syndrome vascular type. There is no particular familial context of arterial hyper- 
tension or atheresclerosis. 
According to both families, aortic dissection/aneurysm with patent ductus artedosus may 
be a new entity due to a common genetic defect that remains to be identified. FamUial 
screening is very important in such a family that is still seldom recognized. 
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